ATE410148T1 - Pharmazeutische zubereitung zur oralen verwendung von heparin und seinen derivaten - Google Patents
Pharmazeutische zubereitung zur oralen verwendung von heparin und seinen derivatenInfo
- Publication number
- ATE410148T1 ATE410148T1 AT02791763T AT02791763T ATE410148T1 AT E410148 T1 ATE410148 T1 AT E410148T1 AT 02791763 T AT02791763 T AT 02791763T AT 02791763 T AT02791763 T AT 02791763T AT E410148 T1 ATE410148 T1 AT E410148T1
- Authority
- AT
- Austria
- Prior art keywords
- heparin
- derivatives
- pharmaceutical preparation
- oral use
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001MI002599A ITMI20012599A1 (it) | 2001-12-11 | 2001-12-11 | Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE410148T1 true ATE410148T1 (de) | 2008-10-15 |
Family
ID=11448679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02791763T ATE410148T1 (de) | 2001-12-11 | 2002-12-03 | Pharmazeutische zubereitung zur oralen verwendung von heparin und seinen derivaten |
Country Status (18)
Country | Link |
---|---|
US (1) | US8642082B2 (de) |
EP (2) | EP1992338B1 (de) |
JP (1) | JP4634713B2 (de) |
KR (2) | KR100984801B1 (de) |
CN (2) | CN100490823C (de) |
AT (1) | ATE410148T1 (de) |
AU (1) | AU2002358082A1 (de) |
CA (1) | CA2465832C (de) |
CY (1) | CY1108625T1 (de) |
DE (1) | DE60229287D1 (de) |
DK (2) | DK1992338T5 (de) |
ES (2) | ES2312652T3 (de) |
HK (1) | HK1072181A1 (de) |
IT (1) | ITMI20012599A1 (de) |
MX (1) | MXPA04005710A (de) |
PT (2) | PT1455761E (de) |
SI (1) | SI1455761T1 (de) |
WO (1) | WO2003049721A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
DE60005819T2 (de) | 1999-06-14 | 2004-05-06 | Cosmo S.P.A. | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe |
US8257744B2 (en) | 2000-07-07 | 2012-09-04 | Laboratorios Farmacéuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
EP2060253A1 (de) | 2007-11-14 | 2009-05-20 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmazeutische Formen zur Freisetzung von Wirkstoffen |
SE0201922D0 (sv) * | 2002-06-20 | 2002-06-20 | Ltp Lipid Technologies Provide | Koagulationshindrande komposition (Anticoagulant Composition) |
ATE552004T1 (de) * | 2005-11-30 | 2012-04-15 | Istituto G Ronzoni | Oral verabreichbare heparinderivate |
US20100004157A1 (en) * | 2006-09-12 | 2010-01-07 | Cosmo Technologies Ltd. | Pharmaceutical compositions for the oral or rectal administration of protein substances |
KR100837558B1 (ko) | 2007-04-30 | 2008-06-12 | (주)아모레퍼시픽 | 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물 |
EP2213282A1 (de) | 2009-01-30 | 2010-08-04 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmazeutische Formen zur Freisetzung von Wirkstoffen |
US8802156B2 (en) | 2007-11-14 | 2014-08-12 | Laboratorios Farmacéuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
KR101291813B1 (ko) | 2011-04-27 | 2013-08-02 | 임승택 | 친수성이 증가된 덱스트린-세라마이드 복합체 및 이의 제조방법 |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
KR20200037574A (ko) | 2018-10-01 | 2020-04-09 | (주)우리비앤비 | 헤파린을 포함하는 탈모방지용 화장료 조성물 |
EP3791884A1 (de) * | 2019-09-16 | 2021-03-17 | Oskar Bunz | Kombination aus heparin und magnesiumsalz zur behandlung viraler infektionen |
CN110585164A (zh) * | 2019-10-08 | 2019-12-20 | 苏州弘森药业股份有限公司 | 一种艾司奥美拉唑镁碳酸氢钠胶囊的制作方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6054313A (ja) | 1983-09-01 | 1985-03-28 | Terumo Corp | 腸管吸収性ヘパリン組成物 |
JP2893191B2 (ja) | 1988-11-08 | 1999-05-17 | 武田薬品工業株式会社 | 放出制御性マトリックス剤 |
IE61651B1 (en) | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
US5665379A (en) | 1990-09-28 | 1997-09-09 | Pharmacia & Upjohn Aktiebolag | Lipid particle forming matrix, preparation and use thereof |
ES2149250T3 (es) | 1993-04-23 | 2000-11-01 | Novartis Ag | Dispositivo para la administracion de medicamentos con liberacion controlada. |
US5665370A (en) * | 1995-02-22 | 1997-09-09 | Temple University Of The Commonwealth System Of Higher Education | Compositions containing cockroach aggregation pheromones, their production and uses |
FR2763848B1 (fr) * | 1997-05-28 | 2000-01-28 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central |
IT1298575B1 (it) | 1998-02-06 | 2000-01-12 | Vectorpharma Int | Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di |
US6423345B2 (en) * | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
WO2000048589A1 (en) * | 1999-02-22 | 2000-08-24 | Emisphere Holdings, Inc. | Solid oral dosage form containing heparin or a heparinoid in combination with a carrier |
ITMI991316A1 (it) * | 1999-06-14 | 2000-12-14 | Cip Ninety Two 92 S A | Composizioni farmaceutiche orali a rilascio modificato di mesalazina |
DE20022960U1 (de) | 1999-11-12 | 2002-07-25 | Emisphere Tech Inc | Flüssige Heparinformulierung |
WO2002092069A1 (en) * | 2001-05-11 | 2002-11-21 | Elan Corporation, Plc | Permeation enhancers |
-
2001
- 2001-12-11 IT IT2001MI002599A patent/ITMI20012599A1/it unknown
-
2002
- 2002-12-03 MX MXPA04005710A patent/MXPA04005710A/es active IP Right Grant
- 2002-12-03 JP JP2003550770A patent/JP4634713B2/ja not_active Expired - Fee Related
- 2002-12-03 CA CA2465832A patent/CA2465832C/en not_active Expired - Fee Related
- 2002-12-03 US US10/498,095 patent/US8642082B2/en not_active Expired - Fee Related
- 2002-12-03 DE DE60229287T patent/DE60229287D1/de not_active Expired - Lifetime
- 2002-12-03 WO PCT/EP2002/013651 patent/WO2003049721A1/en active Application Filing
- 2002-12-03 PT PT02791763T patent/PT1455761E/pt unknown
- 2002-12-03 CN CNB2006100733879A patent/CN100490823C/zh not_active Expired - Fee Related
- 2002-12-03 KR KR1020047008910A patent/KR100984801B1/ko not_active IP Right Cessation
- 2002-12-03 AT AT02791763T patent/ATE410148T1/de active
- 2002-12-03 KR KR1020097011163A patent/KR101062687B1/ko not_active IP Right Cessation
- 2002-12-03 DK DK08160486.0T patent/DK1992338T5/da active
- 2002-12-03 EP EP08160486A patent/EP1992338B1/de not_active Expired - Lifetime
- 2002-12-03 AU AU2002358082A patent/AU2002358082A1/en not_active Abandoned
- 2002-12-03 CN CNB028240812A patent/CN1258360C/zh not_active Expired - Fee Related
- 2002-12-03 ES ES02791763T patent/ES2312652T3/es not_active Expired - Lifetime
- 2002-12-03 SI SI200230768T patent/SI1455761T1/sl unknown
- 2002-12-03 DK DK02791763T patent/DK1455761T3/da active
- 2002-12-03 EP EP02791763A patent/EP1455761B1/de not_active Expired - Lifetime
- 2002-12-03 ES ES08160486T patent/ES2386922T3/es not_active Expired - Lifetime
- 2002-12-03 PT PT08160486T patent/PT1992338E/pt unknown
-
2005
- 2005-03-15 HK HK05102284.6A patent/HK1072181A1/xx not_active IP Right Cessation
-
2008
- 2008-12-08 CY CY20081101416T patent/CY1108625T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1072181A1 (en) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
CY1114708T1 (el) | Παραγωγα πυραζολο-κιναζολινης, διαδικασια για την παρασκευη τους και η χρηση τους ως αναστολεων κινασης | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
ATE508114T1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
DE60239648D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung von Asthma | |
NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
DE60315677D1 (de) | Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
EP1783126A3 (de) | N-Oxide von N-Phenyl-2-Pyrimidinamin Derivaten | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
ATE369355T1 (de) | Pyrimidinamid derivate und deren verwendung | |
DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
HUP0300848A2 (hu) | Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére | |
DE60208044D1 (de) | Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung | |
DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
DE50310080D1 (de) | 3-SUBSTITUIERTE 3,4-DIHYDRO-THIENOi2,3-D PYRIMIDIN-4-ONE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG | |
NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
ATE286894T1 (de) | 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen | |
ATE236905T1 (de) | 4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indol-1- carboxamid-derivate, ihre herstellung und therapeutische verwendung | |
IT1306179B1 (it) | Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale. | |
DE60108354D1 (de) | 2H-1-Benzopyran-Derivative, Prozesse zu ihrer Herstellung und Pharmazeutische Zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1455761 Country of ref document: EP |